Citation Impact
Citing Papers
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination
2001
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Immunotherapy of cancer in 2012
2012
Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization
2001
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
1998 Standout
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
2005
Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A
1996
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Liposome–nucleic acid immunotherapeutics
2007
DNA–based immunization by in vivo transfection of dendritic cells
1996
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo
1997
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Anti-idiotype vaccine against cancer
2000
Design and development of polymers for gene delivery
2005 Standout
Effects of Cocaine Self-administration on Striatal Dopamine Systems in Rhesus Monkeys Initial and Chronic Exposure
2002
Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products
1995
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
2001
Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants
1997
Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization
1997
Special Section:Future Trendsin Vaccination: Advances in cancer vaccine development
1999
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Controlled Delivery of Antigens and Adjuvants in Vaccine Development
1996
The new vaccines: building viruses that elicit antitumor immunity
1996
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
1998
Clinical development of gene therapy for colorectal cancer
2003
Circulating mutant DNA to assess tumor dynamics
2008 Standout
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin
2004
Paradoxical roles of the immune system during cancer development
2006 Standout
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
1998 Standout
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo
2001
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA
1998 StandoutNobel
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Human Clinical Trials of Plasmid DNA Vaccines
2005
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
RNA-based vaccines
2012
DNA and RNA-based vaccines: principles, progress and prospects
1999
The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
2018
Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen
2003
DNA Vaccines: Recent Developments and Future Possibilities
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results
1998
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
The Biology of NKT Cells
2006 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
1996
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
2004
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Characterization of a messenger RNA polynucleotide vaccine vector.
1995
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen
2005
A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex
2006
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
2007 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins
1998 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Contribution of Cells at the Site of DNA Vaccination to the Generation of Antigen-Specific Immunity and Memory
1998
Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques
2007
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
1995
The gene gun: current applications in cutaneous gene therapy
2000
Works of Susan E. Moore being referenced
Intratumoral Administration of a Recombinant Canarypox Virus Expressing Interleukin 12 in Patients with Metastatic Melanoma
2005
The Relationship between Reinforcing Effects and in Vitro Effects of D1 Agonists in Monkeys
1997
A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.
1995
Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
2000
Immune response to a carcinoembryonic antigen polynucleotide vaccine.
1994
Selected strategies to augment polynucleotide immunization.
1996
A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
1995
Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
2002
Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.
1999